Publications are listed below.
Journals
2023
Cellular Signalling, 110, 110815
Habibian, J. S., Bolino, M., Qian, A., Woolsey, R., Quilici, D., Petereit, J., & Ferguson, B. S.
2023
Biomolecules, 13(9), 1274
Evans, L., Price, T., Hubert, N., Moore, J., Shen, Y., Athukorala, M., Frese, S., & Ferguson, B. S.
2023
Biochemical and Biophysical Research Communications, 650, 81-86
Habibian, J. S., Bolino, M. J., & Ferguson, B. S.
2022
J Nutritional Health Aging. 2022 2022;26(7):657-662
Ferguson BS, Sahoo P, McGrail E, Francois A, Stratton MS.
2021
American Journal of Physiology. Heart and Circulatory Physiology, 321(2), H382–H389
Ferguson, B. S., Wennersten, S. A., Demos-Davies, K. M., Rubino, M., Robinson, E. L., Cavasin, M. A., … McKinsey, T. A.
2021
Environmental Pollution, Vol. 282
Alaasam, V. J., Liu, X., Niu, Y., Habibian, J. S., Pieraut, S., Ferguson, B. S., … Ouyang, J. Q.
2021
The Journal of Nutritional Biochemistry, 95, 108631
Shock, T., Badang, L., Ferguson, B., & Martinez-Guryn, K.
2020
Journal of Nutritional Biochemistry
Evans, L., Bender, A., Burnett, L., Godoy, L., Shen, Y., Staten, D., Zhou, T., Angermann, J. E., Ferguson, B.
2019
Future Medicinal Chemistry
Romanick, S., Ferguson, B.
2019
Bioinformatics
Cheng, Q., Khoshdeli, M., Ferguson, B., Jabbari, K., Zang, C., Parvin, B.
2018
Cellular Signaling, Vol 53, Jan. 2019, Pages 234-245
Ferguson, B., Nam, H., Morrison, R.
2018
Nutrients 2018, 10(8)
Evans, L. W., Ferguson, B.
2018
Journal of Animal Science
Silva, L., Ferguson, B., Avila, A., Faciola, A. P.
2018
International Journal of Molecular Sciences
Habibian, J., Ferguson, B.
Natural product inhibitors of acetyl-lysine erasers in the prevention and treatment of heart failure.
2017
Functional Foods in Health and Disease, 7(8), 577-603.
Evans, L. W., Romanick, S. S., Ferguson, B.
Polyphenols: Novel Signaling Pathways.
2017
Current Pharmaceutical Design. 2017 Nov 29. doi: 10.2174/1381612824666171129204054.
Ricketts, M.-L., Ferguson, B.
2017
Journal of Animal Science.
Silva, L., Ferguson, B., Faciola, A. P.
2017
Mol. Nutr. Food Res. 2017, 1600744.
L. D. Godoy, J. E. Lucas, A. J. Bender, S. S. Romanick, B. S. Ferguson,
2017
Journal of Pharmaceutical Sciences and Experimental Pharmacology
Evans, L. W., Romanick, S. S., Ferguson, B.
2016
Molecular nutrition & food research 2016. DOI: 10.1002/mnfr.201600347
Downing LE, Ferguson BS, Rodriguez K, Ricketts ML.
Curcumin Inhibits 3T3-L1 Preadipocyte Proliferation by Mechanisms Involving Post-transcriptional p27 Regulation.
2016
Biochem Biophys Rep.
Ferguson BS, Nam H, Morrison RF.
Histone deacetylase 3 regulates the inflammatory gene expression program of rheumatoid arthritis fibroblast-like synoviocytes
2016
Ann Rheum Dis
Angiolilli C, Kabala PA, Grabiec AM, Van Baarsen IM, Ferguson BS, Fernandez BM, McKinsey TA, Tak PP, Mascagni P, Baeten DL, Reedquist KA
2016
Am J Physiol Lung Cell Mol Physiol.
Nozik-Grayck E, Woods C, Stearman RS, Venkataraman S, Ferguson BS, Swain K, Bowler RP, Geraci MW, Ihida-Stansbury K, Stenmark KR, McKinsey TA, Domann FE.
Inflammatory cytokines epigenetically regulate rheumatoid arthritis fibroblast-like synoviocyte activation by suppressing HDAC5 expression
2016
Ann Rheum Dis.
Angiolilli C, Grabiec AM, Ferguson BS, Ospelt C, Malvar Fernandez B, van Es IE, van Baarsen LG, Gay S, McKinsey TA, Tak PP, Baeten DL, Reedquist KA.
Modulation of IL-27 in adipocytes during inflammatory stress.
2016
Obesity (Silver Spring).
Nam H, Ferguson BS, Stephens JM, Morrison RF.
Signal-Dependent Recruitment of BRD4 to Cardiomyocyte Super-Enhancers Is Suppressed by a MicroRNA
2016
Cell Rep.
Stratton MS, Lin CY, Anand P, Tatman PD, Ferguson BS, Wickers ST, Ambardekar AV, Sucharov CC, Bradner JE, Haldar SM, McKinsey TA
Mitogen-Dependent Regulation of DUSP1 Governs ERK and p38 Signaling During Early 3T3-L1 Adipocyte Differentiation.
2015
J Cell Physiol.
Ferguson BS, Nam H, Stephens JM, Morrison RF.
Non-sirtuin histone deacetylases in the control of cardiac aging.
2015
J Mol Cell Cardiol.
Ferguson BS, McKinsey TA.
Promiscuous actions of small molecule inhibitors of the protein kinase D-class IIa HDAC axis in striated muscle.
2015
FEBS Lett.
Lemon DD, Harrison BC, Horn TR, Stratton MS, Ferguson BS, Wempe MF, McKinsey TA.
Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes.
2014
J Mol Cell Cardiol.
Williams SM, Golden-Mason L, Ferguson BS, Schuetze KB, Cavasin MA, Demos-Davies K, Yeager ME, Stenmark KR, McKinsey TA.
HDAC6 Contributes to Pathological Responses of Heart and Skeletal Muscle to Chronic Angiotensin II Signaling.
2014
Am J Physiol Heart Circ Physiol. Vol. no. DOI: 10.1152/ajpheart.00149
Demos-Davies K, Ferguson BS, Cavasin M, Mahaffey J, Williams SM, Spiltoir J, Schuetze KB, Horn T, Chen B, Ferrera C, Scellini B, Pirooddi N, Tesi C, Poggesi C, Jeong M, and Mckinsey TA.
Tubulin hyperacetylation is adaptive in cardiac proteotoxicity by promoting autophagy.
2014
Proc Natl Acad Sci U S A.
McLendon PM, Ferguson BS, Osinska H, Bhuiyan MS, James J, McKinsey TA, Robbins J.
Impact of obesity on IL-12 family gene expression in insulin responsive tissues.
2013
Biochim Biophys Acta.
Nam H, Ferguson BS, Stephens JM, Morrison RF.
Signal-dependent repression of DUSP5 by class I HDACs controls nuclear ERK activity and cardiomyocyte hypertrophy.
2013
Proc Natl Acad Sci USA (2013);110(24):9806-11
Ferguson BS, Harrison BC, Jeong MY, Reid BC, Wempe MF, Wagner FF, Holson EB, and McKinsey TA.
Impact of reference gene selection for target gene normalization on experimental outcome using real-time qRT-PCR in adipocytes.
2010
PLoS One.
Ferguson BS, Nam H, Hopkins RG, Morrison RF.